nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Note of Thanks
|
|
|
2013 |
35 |
12 |
p. A7-A9 nvt p. |
artikel |
2 |
Author Index
|
|
|
2013 |
35 |
12 |
p. 2036-2040 5 p. |
artikel |
3 |
Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) Formulation and Paclitaxel in Polyethoxylated Castor Oil: A Randomized, Two-Period Crossover Study in Patients With Advanced Cancer
|
Slingerland, Marije |
|
2013 |
35 |
12 |
p. 1946-1954 9 p. |
artikel |
4 |
Cardiac Repolarization With Gabapentin Enacarbil in a Randomized, Double-Blind, Placebo- and Active-Controlled, Crossover Thorough QT/QTc Study in Healthy Adults
|
Davy, Maria |
|
2013 |
35 |
12 |
p. 1964-1974 11 p. |
artikel |
5 |
Comparison of the Effects of Amlodipine and Losartan on Blood Pressure and Diurnal Variation in Hypertensive Stroke Patients: A Prospective, Randomized, Double-Blind, Comparative Parallel Study
|
Kwon, Hyung-Min |
|
2013 |
35 |
12 |
p. 1975-1982 8 p. |
artikel |
6 |
Comparison of the Efficacy of Lamivudine Plus Adefovir Versus Entecavir in the Treatment of Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis
|
Huang, Ze-Bing |
|
2013 |
35 |
12 |
p. 1997-2006 10 p. |
artikel |
7 |
Cost-Effectiveness of Everolimus for Second-Line Treatment of Metastatic Renal Cell Carcinoma in Serbia
|
Mihajlović, Jovan |
|
2013 |
35 |
12 |
p. 1909-1922 14 p. |
artikel |
8 |
Diagnoses Associated With Use of Atypical Antipsychotics in a Commercial Health Plan: A Claims Database Analysis
|
Citrome, Leslie |
|
2013 |
35 |
12 |
p. 1867-1875 9 p. |
artikel |
9 |
Economic Burden of Adverse Events in Patients With Metastatic Renal Cell Carcinoma
|
Hagiwara, May |
|
2013 |
35 |
12 |
p. 1955-1963.e2 194346 p. |
artikel |
10 |
Etamicastat, a Novel Dopamine β-Hydroxylase Inhibitor: Tolerability, Pharmacokinetics, and Pharmacodynamics in Patients With Hypertension
|
Almeida, Luis |
|
2013 |
35 |
12 |
p. 1983-1996 14 p. |
artikel |
11 |
Evaluation of the Effect of Naloxegol on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled Crossover Thorough QT/QTc Study in Healthy Volunteers
|
Gottfridsson, Christer |
|
2013 |
35 |
12 |
p. 1876-1883 8 p. |
artikel |
12 |
Hydromorphone: Evolving to Meet the Challenges of Today’s Health Care Environment
|
Gregory, Thomas B. |
|
2013 |
35 |
12 |
p. 2007-2027 21 p. |
artikel |
13 |
Is It Possible to Withdraw Biologics From Therapy in Rheumatoid Arthritis?
|
Tanaka, Yoshiya |
|
2013 |
35 |
12 |
p. 2028-2035 8 p. |
artikel |
14 |
Pharmacokinetic and Safety Profile of Ivabradine in Healthy Chinese Men: A Phase I, Randomized, Open-Label, Increasing Single- and Multiple-Dose Study
|
Jiang, Juanjuan |
|
2013 |
35 |
12 |
p. 1933-1945 13 p. |
artikel |
15 |
Pharmacokinetics and Tolerability of Tenofovir Disoproxil Fumarate 300 mg Once Daily: An Open-Label, Single- and Multiple-Dose Study in Healthy Chinese Subjects
|
Hu, Chao-ying |
|
2013 |
35 |
12 |
p. 1884-1889 6 p. |
artikel |
16 |
Reflections on 2013, the Beginning of 2014, and the Food and Drug Administration’s New Expedited Approval Program Known as Breakthrough Product Designation
|
Shader, Richard I. |
|
2013 |
35 |
12 |
p. 1865-1866 2 p. |
artikel |
17 |
Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia
|
Mitchell, Malcolm |
|
2013 |
35 |
12 |
p. 1890-1908 19 p. |
artikel |
18 |
Subject Index
|
|
|
2013 |
35 |
12 |
p. 2041-2058 18 p. |
artikel |
19 |
Treatment Patterns, HealthCare Resource Utilization and Costs in Patients with Bipolar Disorder, Newly Treated with Extended Release or Immediate Release Quetiapine Fumarate using US Healthcare Administrative Claims Data
|
Locklear, Julie C. |
|
2013 |
35 |
12 |
p. 1923-1932 10 p. |
artikel |